Vasudevan SG - Search Results

1

Animal models for studying dengue pathogenesis and therapy.

Chan KW, Watanabe S, Kavishna R, Alonso S, Vasudevan SG. Chan KW, et al. Among authors: vasudevan sg. Antiviral Res. 2015 Nov;123:5-14. doi: 10.1016/j.antiviral.2015.08.013. Epub 2015 Aug 21. Antiviral Res. 2015. PMID: 26304704 Review.

2

Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing.

Ng CY, Gu F, Phong WY, Chen YL, Lim SP, Davidson A, Vasudevan SG. Ng CY, et al. Among authors: vasudevan sg. Antiviral Res. 2007 Dec;76(3):222-31. doi: 10.1016/j.antiviral.2007.06.007. Epub 2007 Jul 26. Antiviral Res. 2007. PMID: 17662475

3

Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.

Lescar J, Luo D, Xu T, Sampath A, Lim SP, Canard B, Vasudevan SG. Lescar J, et al. Among authors: vasudevan sg. Antiviral Res. 2008 Nov;80(2):94-101. doi: 10.1016/j.antiviral.2008.07.001. Epub 2008 Jul 30. Antiviral Res. 2008. PMID: 18674567 Review.

4

A scintillation proximity assay for dengue virus NS5 2'-O-methyltransferase-kinetic and inhibition analyses.

Lim SP, Wen D, Yap TL, Yan CK, Lescar J, Vasudevan SG. Lim SP, et al. Among authors: vasudevan sg. Antiviral Res. 2008 Dec;80(3):360-9. doi: 10.1016/j.antiviral.2008.08.005. Epub 2008 Sep 20. Antiviral Res. 2008. PMID: 18809436

5

Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity.

Paradkar PN, Ooi EE, Hanson BJ, Gubler DJ, Vasudevan SG. Paradkar PN, et al. Among authors: vasudevan sg. Biosci Rep. 2011 Jun;31(3):221-30. doi: 10.1042/BSR20100078. Biosci Rep. 2011. PMID: 20858223

6

High affinity human antibody fragments to dengue virus non-structural protein 3.

Moreland NJ, Tay MY, Lim E, Paradkar PN, Doan DN, Yau YH, Geifman Shochat S, Vasudevan SG. Moreland NJ, et al. Among authors: vasudevan sg. PLoS Negl Trop Dis. 2010 Nov 9;4(11):e881. doi: 10.1371/journal.pntd.0000881. PLoS Negl Trop Dis. 2010. PMID: 21085466 Free PMC article.

7

Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.

Schüller A, Yin Z, Brian Chia CS, Doan DN, Kim HK, Shang L, Loh TP, Hill J, Vasudevan SG. Schüller A, et al. Among authors: vasudevan sg. Antiviral Res. 2011 Oct;92(1):96-101. doi: 10.1016/j.antiviral.2011.07.002. Epub 2011 Jul 8. Antiviral Res. 2011. PMID: 21763725

8

Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model.

Rathore AP, Paradkar PN, Watanabe S, Tan KH, Sung C, Connolly JE, Low J, Ooi EE, Vasudevan SG. Rathore AP, et al. Among authors: vasudevan sg. Antiviral Res. 2011 Dec;92(3):453-60. doi: 10.1016/j.antiviral.2011.10.002. Epub 2011 Oct 12. Antiviral Res. 2011. PMID: 22020302

9

Expression and immunoaffinity purification of recombinant dengue virus 2 NS1 protein as a cleavable SUMOstar fusion.

Rozen-Gagnon K, Moreland NJ, Ruedl C, Vasudevan SG. Rozen-Gagnon K, et al. Among authors: vasudevan sg. Protein Expr Purif. 2012 Mar;82(1):20-5. doi: 10.1016/j.pep.2011.11.003. Epub 2011 Nov 11. Protein Expr Purif. 2012. PMID: 22100526

10

The magnitude of dengue virus NS1 protein secretion is strain dependent and does not correlate with severe pathologies in the mouse infection model.

Watanabe S, Tan KH, Rathore AP, Rozen-Gagnon K, Shuai W, Ruedl C, Vasudevan SG. Watanabe S, et al. Among authors: vasudevan sg. J Virol. 2012 May;86(10):5508-14. doi: 10.1128/JVI.07081-11. Epub 2012 Mar 14. J Virol. 2012. PMID: 22419801 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page